Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02362750 · ClinicalTrials.gov registry record
Evaluating Cancer Survivorship Care Models
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 991
- Enrollment target
NCT02362750: Completed study, sponsored by George Washington University.
NCT02362750 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 991 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02362750 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 991 participants
- Enrollment target
Study Summary
The Evaluating Cancer Survivorship Care Models project is an innovative 3-year study that is collecting data to help understand how to best deliver follow-up care to cancer survivors. Cancer is a complex disease requiring complex treatments that can cause lasting impacts after treatment ends. Some patients face physical, psychosocial, spiritual and/or practical challenges as they adjust to life after cancer. Fortunately, health care providers have begun to focus on the consequences of cancer and its treatment and are more actively working with cancer survivors to manage post-treatment needs and care. Led by the George Washington University and funded by the Patient-Centered Outcomes Research Institute, this project brings together representatives from the Commission on Cancer, the Cancer Support Community, LIVESTRONG and the American Cancer Society as well as cancer survivors and healthcare professionals to better understand how different strategies or models of care impact outcomes that are most important to cancer survivors. The project will focus on survivors of breast, prostate and colorectal cancers and will be relevant for understanding the needs and preferences of survivors of other cancers as well. The emphasis is on patient-centered outcomes, which are outcomes that are most significant to patients, such as patient satisfaction and quality of life.
Primary Outcome
Patient-reported quality of care was measured using the Survivorship Care Quality Index, which consists of 9 factors and a total of 46 metrics. The factors are then grouped into domains. Domain 1, Informed and grounded patients, consist of 2 factors: 1) delivering mental health and social support, and 2) providing information and resources on the expectations of survivorship care. Domain 2, the patient-provider alliance, consists of 3 factors: 1) feeling empowered to engage in their care, 2) hav
Interventions
- OTHER Consultative Specialized Survivorship Clinic (CSSC)
- OTHER Longitudinal Specialized Survivorship Clinic (LSSC)
- OTHER Oncology Embedded Survivorship Clinic (OESC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 991 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-10 |
What the finished NCT02362750 record still lists
NCT02362750 is an observational study that tracks outcomes without assigning an intervention. The registered 991 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Consultative Specialized Survivorship Clinic (CSSC) is the first listed.
NCT02362750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02362750 about?
NCT02362750 is a clinical study titled "Evaluating Cancer Survivorship Care Models". The Evaluating Cancer Survivorship Care Models project is an innovative 3-year study that is collecting data to help understand how to best deliver follow-up care to cancer survivors. Cancer is a complex disease requiring complex treatments that can cause lasting impacts after treatment ends. Some p...
What is the current status of trial NCT02362750?
This trial is currently completed. The enrollment target is 991 participants. The study started on 2013-07. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02362750?
The interventions under investigation include: Consultative Specialized Survivorship Clinic (CSSC) (OTHER), Longitudinal Specialized Survivorship Clinic (LSSC) (OTHER), Oncology Embedded Survivorship Clinic (OESC) (OTHER).
Who is sponsoring clinical trial NCT02362750?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05987241 · 992 participants · Phase 2
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
- NCT05441709 · 990 participants · NA
Furthering Equity Through Infant Feeding EDucation and Support
- NCT06340646 · 990 participants · NA
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- NCT06878261 · 990 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia